BIOREGENX, INC. (BRGX)
BioRegenx, Inc. develops, manufactures, and sells medical test equipment, science-based nutritional products, and AI-driven health monitoring technologies. Its products include the GlycoCheck system for microvascular health assessment, the Endocalyx Pro dietary supplement, and the DocSun AI engine for contactless vital sign monitoring. The company focuses on regenerative biotherapeutics, anti-aging, and non-invasive medical and wellness devices.
Sector: Services-Computer Programming, Data Processing, Etc.
Industry: Medical - Instruments & Supplies
BioRegenx, Inc.
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
based on 971.58M shares outstanding
USBioRegenx, Inc. develops, manufactures, and sells medical test equipment and science-based nutritional products in the United States and internationally.
The company offers Endocalyx Pro, a dietary supplement targeting microvascular capillary health and a range of other supplements under the MyBodyRx brand name; GlycoCheck software; and other health and wellness devices, such as pulsed electro-magnetic field devices, as well as StimaWELL and ReLounge, an electronic muscle stimulation therapy device; and markets hydrogen water products.
It also develops TruScan.Ai mobile app/website that integrates additional health indicators; and VitalWellness app, which merge its DNA and epigenetics platform.
In addition, the company operates a social media content management platform, including its interactive search engine. Further, it provides DocSun Artificial Intelligence (AI) Engine, which integrates advanced ballistocardiography that detects an individual's heartbeat without touch; photoplethysmography, a method that uses light to track the flow of blood; and distributes wellness devices.
The company sells its products through a direct selling channel to health professionals and research organizations. BioRegenx, Inc. is headquartered in Chattanooga, Tennessee.
Leadership
William Resides
CEO, Interim CFO, Chairman, & Executive Director
Gary Hennerberg
Secretary
Diane Bouis
Acting Chief Executive Officer MVHS
Employees
5
Country
US
Sector
Technology
Website
bioregenx.com
based on 971.58M shares outstanding
US30d Avg
163.18K
60d Avg
154.83K
90d Avg
127.98K